Phortas

Foundation date

01/08/2017

Sector

#Professional Services and Consulting

Subsector

Phortas is an independent expert consultancy in the Regulatory Affairs and pharmaceutical product development field.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023